Jan 31, 2018 | Featured Insights
Proskauer represented Celgene Corporation in its definitive agreement to acquire Juno Therapeutics, Inc. Under the terms of the merger agreement, Celgene will pay $87 per share in cash, or a total of approximately $9 billion, net of cash and marketable securities... 
Jan 25, 2018 | Featured Insights
Marcus Neiman & Rashbaum lawyers represented three physicians whose ownership shares were undervalued by their Miami hospital following a merger. Michael Pineiro and Daniel Rashbaum represented the plaintiffs in Miami-Dade Circuit Court. Judge Jorge Cueto found...